Michael Lachman is founder and president of EyeQ Research, the leading consulting partner for strategic transactions in eye care. EyeQ Research provides consulting services to innovators and investors in eye care, including financial modeling and business valuation, proprietary market research, due diligence, and strategic advisory. Michael brings 30 years of experience in medical technology, including consulting, investment research, business development, marketing, and engineering. His active involvement in the ophthalmology sector spans over 20 years. Before launching EyeQ Research in 2005, Michael was a Managing Director and equity research analyst with ThinkEquity Partners, healthcare analyst with SAC Capital Advisors, and medical device analyst with Hambrecht & Quist, where he received a #1 ranking in medical industry stock picking in the Wall Street Journal All-Star Analyst Survey. Michael worked for five years in business development for Johnson & Johnson and for seven years in marketing and R&D with Baxter. Michael holds an MBA from Northwestern University’s Kellogg School of Management, an MS in Mechanical Engineering from Stanford University, and a BS in Aeronautical Engineering with highest honors from the University of Illinois.